P
Parisa Mansoori
Researcher at University of Edinburgh
Publications - 29
Citations - 378
Parisa Mansoori is an academic researcher from University of Edinburgh. The author has contributed to research in topics: Medicine & Psychological intervention. The author has an hindex of 10, co-authored 26 publications receiving 307 citations. Previous affiliations of Parisa Mansoori include Tehran University of Medical Sciences & Mazandaran University of Medical Sciences.
Papers
More filters
Journal ArticleDOI
Comparison of cryotherapy and curettage for the treatment of pyogenic granuloma: a randomized trial.
TL;DR: This poster focuses on the treatment of pyogenic granuloma, which is a benign vascular lesion of the skin and mucous membranes and has had many different treatments, with variable success rates.
Journal ArticleDOI
Computer-aided dermoscopy for diagnosis of melanoma
Masoomeh Barzegari,Haiedeh Ghaninezhad,Parisa Mansoori,Arash Taheri,Zahra S. Naraghi,M Asgari +5 more
TL;DR: The diagnostic accuracy of the dermoscopy system was at the level of clinical examination by dermatologists with naked eyes, suggesting this system may represent a useful tool for screening of melanoma, particularly at centers not experienced in the field of pigmented skin lesions.
Journal ArticleDOI
50 years of Iranian clinical, biomedical, and public health research: a bibliometric analysis of the Web of Science Core Collection (1965-2014).
TL;DR: In Iran, a great capacity for research lies in clinical, biomedical, and public health fields which can be strengthened with further investment, and it is important to use this capacity in a way that would align with the national population health needs.
Journal Article
A Randomized, Double-blind, Placebo - controlled Study of Safety of the Adjunctive Saffron on Sexual Dysfunction Induced by a Selective Serotonin Reuptake Inhibitor
Parisa Mansoori,Shahin Akhondzadeh,Firoozeh Raisi,Padideh Ghaeli,A H Jamshidi,Abbas-Ali Nasehi,Hamid Sohrabi,Sepideh Saroukhani +7 more
TL;DR: Saffron as an add-on medication to SSRIs for 4 weeks did not cause any statistically significant changes in laboratory parameters including AST, ALT, ALP, BUN, Cr.
Journal ArticleDOI
Efficacy of Zinc Sulfate as an Add-on Therapy to Risperidone Versus Risperidone Alone in Patients With Schizophrenia: A Double-Blind Randomized Placebo-Controlled Trial.
Mehran Mortazavi,Davood Farzin,Mehran Zarhghami,Seyed Hamzeh Hosseini,Parisa Mansoori,Gholamreza Nateghi +5 more
TL;DR: It may be concluded that Zn is an effective adjuvant agent in the management of patients with schizophrenia and improvement was significantly higher in Zn sulfate receiving group compared to the placebo group.